Free Trial

Viridian Therapeutics (VRDN) Competitors

Viridian Therapeutics logo
$19.23 +1.21 (+6.71%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$19.09 -0.14 (-0.73%)
As of 08/22/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VRDN vs. RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, PRVA, HTFL, and VCYT

Should you be buying Viridian Therapeutics stock or one of its competitors? The main competitors of Viridian Therapeutics include RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Heartflow (HTFL), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

Viridian Therapeutics vs. Its Competitors

Viridian Therapeutics (NASDAQ:VRDN) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

RadNet has a net margin of -0.78% compared to Viridian Therapeutics' net margin of -112,806.88%. RadNet's return on equity of 2.41% beat Viridian Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Viridian Therapeutics-112,806.88% -78.95% -49.91%
RadNet -0.78%2.41%0.82%

Viridian Therapeutics has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500. Comparatively, RadNet has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500.

77.9% of RadNet shares are owned by institutional investors. 1.6% of Viridian Therapeutics shares are owned by company insiders. Comparatively, 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

RadNet has higher revenue and earnings than Viridian Therapeutics. RadNet is trading at a lower price-to-earnings ratio than Viridian Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viridian Therapeutics$300K5,234.41-$269.95M-$3.83-5.02
RadNet$1.83B2.95$2.79M-$0.20-350.50

In the previous week, RadNet had 24 more articles in the media than Viridian Therapeutics. MarketBeat recorded 25 mentions for RadNet and 1 mentions for Viridian Therapeutics. RadNet's average media sentiment score of 1.00 beat Viridian Therapeutics' score of 0.48 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Viridian Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
RadNet
16 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Viridian Therapeutics currently has a consensus price target of $37.00, indicating a potential upside of 92.41%. RadNet has a consensus price target of $71.60, indicating a potential upside of 2.14%. Given Viridian Therapeutics' higher possible upside, equities research analysts plainly believe Viridian Therapeutics is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viridian Therapeutics
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
RadNet
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.25

Summary

RadNet beats Viridian Therapeutics on 13 of the 17 factors compared between the two stocks.

Get Viridian Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRDN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VRDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRDN vs. The Competition

MetricViridian TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.47B$3.11B$5.76B$9.58B
Dividend YieldN/A2.23%4.41%4.10%
P/E Ratio-5.0220.8831.1026.04
Price / Sales5,234.41343.33433.45102.77
Price / CashN/A43.1937.7358.48
Price / Book4.818.129.536.61
Net Income-$269.95M-$54.72M$3.26B$265.56M
7 Day Performance3.72%2.63%2.10%1.97%
1 Month Performance7.13%2.78%2.81%-0.36%
1 Year Performance27.77%11.01%30.56%19.03%

Viridian Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRDN
Viridian Therapeutics
1.6214 of 5 stars
$19.23
+6.7%
$37.00
+92.4%
+25.4%$1.47B$300K-5.0250
RDNT
RadNet
3.2944 of 5 stars
$66.29
-1.7%
$71.60
+8.0%
+9.4%$5.19B$1.83B-331.4311,021News Coverage
Insider Trade
OPCH
Option Care Health
4.556 of 5 stars
$28.19
-0.5%
$35.75
+26.8%
-7.5%$4.60B$5.00B22.558,088News Coverage
Positive News
Insider Trade
Gap Up
SHC
Sotera Health
1.397 of 5 stars
$15.80
+0.4%
$16.00
+1.3%
+8.2%$4.47B$1.10B197.523,000News Coverage
BTSG
BrightSpring Health Services
1.6991 of 5 stars
$23.09
+2.9%
$25.67
+11.2%
+107.8%$3.98B$11.27B74.4935,000Positive News
WGS
GeneDx
2.1879 of 5 stars
$125.90
-0.4%
$101.63
-19.3%
+278.2%$3.63B$305.45M2,518.001,200Positive News
Insider Trade
CON
Concentra Group Holdings Parent
2.3451 of 5 stars
$22.85
-1.7%
$28.50
+24.8%
+2.2%$2.98B$1.90B19.2011,250News Coverage
Positive News
SGRY
Surgery Partners
3.0154 of 5 stars
$22.49
-1.4%
$33.00
+46.7%
-17.5%$2.92B$3.11B-15.7315,000News Coverage
PRVA
Privia Health Group
4.2814 of 5 stars
$21.37
+0.5%
$28.00
+31.0%
+9.9%$2.61B$1.74B194.291,140News Coverage
Positive News
Analyst Upgrade
HTFL
Heartflow
N/A$29.97
-3.8%
N/AN/A$2.53BN/A0.00699
VCYT
Veracyte
2.8427 of 5 stars
$30.07
-0.5%
$40.90
+36.0%
-0.2%$2.38B$445.76M91.12790News Coverage

Related Companies and Tools


This page (NASDAQ:VRDN) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners